香港亞欣國際藥業(yè)有限公司是一家跨國際領先水平的高科技型企業(yè)，公司總部位于中國香港九龍區(qū)。擁有雄厚的經濟實力、先進的生產設備、優(yōu)秀的科研開發(fā)隊伍及其高素質的市場管理人員，公司主營高尖端生物制劑、原裝進口生物制劑；是一家著名的投資與生物技術研發(fā)機構，主要涉及生物工程、醫(yī)學、農業(yè)三大領域，公司于2009年進入大陸（上海總辦事處），在國內上海、廈門、鄭州、北京均設有營銷中心和生產基地。
香港亞欣國際藥業(yè)有限公司主要從事高尖端生物制品的研發(fā)、生產和銷售等工作。公司對于高科技新產品的研發(fā)始終放在首位，公司采用先進的高效液相紫外分析檢測儀器、靶向技術，為產品進行全程質量監(jiān)控，確保穩(wěn)定高效的產品質量。目前公司已經根據中國養(yǎng)殖業(yè)的發(fā)展需要開發(fā)了多款新產品，如血清抗體，卵黃抗體，刀豆素、胸腺肽，干擾素，進口cc肽，克羅因子等高科技無殘留生物制品。對豬、牛、羊、雞、鴨、鵝、飛禽、寵物以及特種動物等高致命性疾病具有很強的控制能力。得到了業(yè)內的廣泛認可。在全國20多個省、市、自治區(qū)形成覆蓋廣、功能強的營銷網絡。
Hong Kong xin international pharmaceutical co., LTD. Is an international leading level of high science and technology enterprises, the company is headquartered in Hong Kong, China, Kowloon. With strong economic strength, advanced production equipment, excellent research and development team and high quality market management personnel, the company's main sophisticated biological agents, imported from biological preparation; Is a famous investment and biotechnology research and development institutions, mainly involves three areas, biological engineering, medicine, agriculture company (Shanghai office) in 2009 into the mainland, in the domestic Shanghai, xiamen, zhengzhou, Beijing has marketing center and production base.
Hong Kong xin international pharmaceutical co., LTD is mainly engaged in cutting-edge research and development, production and sales of biological products. Company to high-tech research and development of new products always in the first place, the company USES the advanced detection instruments, targeting technology, uv and HPLC analysis for product quality monitoring, to ensure stable and efficient product quality. At present, the company has according to the needs of the development of China's aquaculture has developed many new products, such as serum antibody, yolk antibody, sword bean element, uct, interferon, import cc peptide, crow factor is no residual on high-tech biological products. For pigs, cattle, sheep, chickens, ducks, geese, birds, pets and special animal such as a deadly disease has a strong control ability. The industry wide recognition. Across the country more than 20 provinces, municipalities and autonomous regions to form function of wide coverage, strong marketing network. |
